Photonic technologies have seen revolutionary developments in the past decades leading from conventional optics to on-chip photonic devices. Mid-infrared (3-15 μm; MIR) sensor technology has nowadays evolved into a state-of-the-art tool for the selective and sensitive quantification of trace analytes in liquid, solid, and gaseous state in a wide variety of sensing scenarios. In this presentation, we will discuss the unique combination of mid-infrared photonics sensors with electronic nose systems for the analysis of biomarker panels in exhaled breath that are indicative of gastric cancer. Within a multi-national initiative, six so-called VOGAS analyzers were deployed around the world for screening patients establishing the utility of this innovative method.
No takes yet. Share an insight, caveat, or question.
Boris Mizaikoff (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: